Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
Anvisa prioritizes registration of dengue devices
Anvisa has decided to prioritize registration for dengue diagnosis in order to guarantee an agile and effective response to the epidemic....
Anvisa extends the validity period of the Good Practices Certificate
Anvisa extends the duration of the Good Practices Certificate to 4 years, applying to companies under the MDSAP....
Infarmed approves marketing of three cannabis products
Infarmed has approved three authorizations to place cannabis-based preparations on the market for medicinal purposes....
Anvisa joins the OAS Program – Full integration
Anvisa approved a joint ordinance with the Brazilian Federal Revenue Service, allowing it to participate in the Integrated AEO Program....
Anvisa – Innovative new regulations for the food sector
Anvisa has published the new regulatory framework for the regularization of food in the context of the National Health Surveillance System....
Anvisa announces selection of innovative medical devices
visa chose ten innovative projects for the pilot project, which were announced at the Technological Advances in Medical Devices Seminar....
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.